Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Staffurth

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Cancer Immunology Research|February 14, 2015
Cross-Presentation of the Oncofetal Tumor Antigen 5T4 from Irradiated Prostate Cancer Cells--A Key Role for Heat-Shock Protein 70 and Receptor CD91Josephine Salimu, Lisa K Spary, Saly Al-Taei, et al.
Anticancer Research|September 27, 2015
What Predicts Minimal Response to Abiraterone in Metastatic Castrate-resistant Prostate Cancer?Rhian Siân Davies, Christian Smith, Michael Robert Button, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 8, 2016
Comparison of investigator-delineated gross tumour volumes and quality assurance in pancreatic cancer: Analysis of the on-trial cases for the SCALOP trialEmmanouil Fokas, Emiliano Spezi, Neel Patel, et al.
Radiation Oncology (London, England)|November 21, 2015
The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: a radiobiological investigationRhys Carrington, John Staffurth, Samantha Warren, et al.
Molecular & Cellular Proteomics : MCP|March 13, 2010
Proteomics analysis of bladder cancer exosomesJoanne L Welton, Sanjay Khanna, Peter J Giles, et al.
International Journal of Radiation Oncology, Biology, Physics|August 11, 2012
Toward semi-automated assessment of target volume delineation in radiotherapy trials: the SCOPE 1 pretrial test caseSarah Gwynne, Emiliano Spezi, Lucy Wills, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 3, 2015
Comparison of investigator-delineated gross tumor volumes and quality assurance in pancreatic cancer: Analysis of the pretrial benchmark case for the SCALOP trialEmmanouil Fokas, Charlotte Clifford, Emiliano Spezi, et al.
Physics and Imaging in Radiation Oncology|January 18, 2021
Utilisation of Pareto navigation techniques to calibrate a fully automated radiotherapy treatment planning solutionPhilip A Wheeler, Michael Chu, Rosemary Holmes, et al.
The British Journal of Radiology|June 2, 2016
Prospective review of radiotherapy trials through implementation of standardized multicentre workflow and IT infrastructureSarah Gwynne, Gareth Jones, Rhydian Maggs, et al.
Medical Oncology (Northwood, London, England)|September 13, 2013
Time to prostate specific antigen (PSA) nadir may predict rapid relapse in men with metastatic castration-resistant prostate cancer (CRPC) receiving docetaxel chemotherapyBetsan M Thomas, Christian Smith, Jessica Evans, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Cancer Immunology Research|February 14, 2015
Cross-Presentation of the Oncofetal Tumor Antigen 5T4 from Irradiated Prostate Cancer Cells--A Key Role for Heat-Shock Protein 70 and Receptor CD91Josephine Salimu, Lisa K Spary, Saly Al-Taei, et al.
Anticancer Research|September 27, 2015
What Predicts Minimal Response to Abiraterone in Metastatic Castrate-resistant Prostate Cancer?Rhian Siân Davies, Christian Smith, Michael Robert Button, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 8, 2016
Comparison of investigator-delineated gross tumour volumes and quality assurance in pancreatic cancer: Analysis of the on-trial cases for the SCALOP trialEmmanouil Fokas, Emiliano Spezi, Neel Patel, et al.
Radiation Oncology (London, England)|November 21, 2015
The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: a radiobiological investigationRhys Carrington, John Staffurth, Samantha Warren, et al.
Molecular & Cellular Proteomics : MCP|March 13, 2010
Proteomics analysis of bladder cancer exosomesJoanne L Welton, Sanjay Khanna, Peter J Giles, et al.
International Journal of Radiation Oncology, Biology, Physics|August 11, 2012
Toward semi-automated assessment of target volume delineation in radiotherapy trials: the SCOPE 1 pretrial test caseSarah Gwynne, Emiliano Spezi, Lucy Wills, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 3, 2015
Comparison of investigator-delineated gross tumor volumes and quality assurance in pancreatic cancer: Analysis of the pretrial benchmark case for the SCALOP trialEmmanouil Fokas, Charlotte Clifford, Emiliano Spezi, et al.
Physics and Imaging in Radiation Oncology|January 18, 2021
Utilisation of Pareto navigation techniques to calibrate a fully automated radiotherapy treatment planning solutionPhilip A Wheeler, Michael Chu, Rosemary Holmes, et al.
The British Journal of Radiology|June 2, 2016
Prospective review of radiotherapy trials through implementation of standardized multicentre workflow and IT infrastructureSarah Gwynne, Gareth Jones, Rhydian Maggs, et al.
Medical Oncology (Northwood, London, England)|September 13, 2013
Time to prostate specific antigen (PSA) nadir may predict rapid relapse in men with metastatic castration-resistant prostate cancer (CRPC) receiving docetaxel chemotherapyBetsan M Thomas, Christian Smith, Jessica Evans, et al.
Pageof 9